NM_199352.6:c.1561C>G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_199352.6(SLC22A25):c.1561C>G(p.Gln521Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,613,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_199352.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152096Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 250906 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461702Hom.: 0 Cov.: 29 AF XY: 0.0000481 AC XY: 35AN XY: 727148 show subpopulations
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74302 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1561C>G (p.Q521E) alteration is located in exon 9 (coding exon 9) of the SLC22A25 gene. This alteration results from a C to G substitution at nucleotide position 1561, causing the glutamine (Q) at amino acid position 521 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at